Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ESKETAMINE vs ESLICARBAZEPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ESKETAMINE vs ESLICARBAZEPINE: Safety Overview

Metric ESKETAMINE ESLICARBAZEPINE
Total FAERS Reports 15,132 3,127
Deaths Reported 637 97
Death Rate 4.2% 3.1%
Hospitalizations 2,919 750
Average Patient Age 47.8 yrs 42.8 yrs
% Female Patients 67.0% 56.8%
FDA Approval Date Mar 5, 2019 Aug 3, 2023
Manufacturer Janssen Pharmaceuticals Inc. Apotex Corp.
Route NASAL ORAL
Marketing Status Prescription Prescription